TScan Therapeutics, Inc.

NASDAQ:TCRX

Biotechnology

Healthcare
$0.82 +2.23%

+$0.02 today

Market cap
$50.37M
Beta
1.03
P/E (TTM)
-1.0
EPS (TTM)
-$0.96
52W Low $0.85High $2.57

Volume 0.00M

Average 0.81M

Price history

TScan Therapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-19.93%

Period high

$1.43

Period low

$0.82

Latest

$0.82

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
8-KJun 22, 2026Jun 22, 2026
4May 22, 2026May 22, 2026
4May 22, 2026May 22, 2026
4May 22, 2026May 22, 2026
8-KMay 22, 2026May 22, 2026
4May 22, 2026May 22, 2026
4May 22, 2026May 22, 2026
4May 22, 2026May 22, 2026
SC 13G/AMay 15, 2026May 15, 2026
10-QMay 6, 2026May 6, 2026
8-KMay 6, 2026May 6, 2026
ARSApr 17, 2026Apr 17, 2026
DEF 14AApr 17, 2026Apr 17, 2026
PRE 14AApr 7, 2026Apr 7, 2026
8-KApr 2, 2026Apr 2, 2026

Competitors

Who does TScan Therapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about TCRX's filings, answered from its disclosures.

What is the latest TCRX filing?

The latest filing shown is 8-K dated Jun 22, 2026.

How many recent filings does TCRX have?

Intrinsic Alpha currently shows 20 recent filings for TCRX.